Co Q10 and Semen parameter
Phase 2
- Conditions
- Male Infertility.Male infertility
- Registration Number
- IRCT138706031079N1
- Lead Sponsor
- Avicenna Research Institute; Tehran Medical Sciences University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Inclusion : idiopathic oligoasthenoteratospermia, normal profile for hormones, normal genital anatomy
Exclusion: major infection in genital organ, treatment for systemic disease during the last three months of inclusion, surgery background on genitalia, exposure to chemicals ,solvents or heavy metals, supplementation therapy in last three months of inclusion
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Semen analysis. Timepoint: 45 days , 90days. Method of measurement: HPLC, flourometry , spectrophotometry, ELIZA.;Sperm Isoprostan concentration. Timepoint: 45 days , 90days. Method of measurement: ELIZA.;Activity of seminal plasma catalase. Timepoint: 45 days , 90days. Method of measurement: spectrophotometry.;Activity of seminal plasma superoxide dysmutase. Timepoint: 45 days , 90days. Method of measurement: spectrophotometry.;Seminal plasma ubiquinone concentration. Timepoint: 45 days , 90days. Method of measurement: HPLC.;DNA fregmentation. Timepoint: 45 days , 90days. Method of measurement: Flowcytometry.
- Secondary Outcome Measures
Name Time Method Seminal plasma gluthation reductase. Timepoint: 45 days, 90 days. Method of measurement: spectrophotometry.;Total Antioxidant Capacity(TAC). Timepoint: 45 days, 90 days. Method of measurement: spectrophotometry.;Seminal plasma Coenzyme Q10. Timepoint: 45 days, 90 days. Method of measurement: HPLC.;Seminal plasma gluthation peroxidase. Timepoint: 45 days, 90 days. Method of measurement: spectrophotometry.